Archive for 2007/11


Pittsburgh Based Associates In Ophthalmology Now Offers Patients Nutritional Vitamin Supplements Through A Partnership With Douglas Laboratories

Pittsburgh based Associates in Ophthalmology (AIO), is very pleased to announce a new program offering nutritional vitamin supplements to promote eye care through a partnership with Douglas Laboratories. For over a century, Associates in Ophthalmology and the talented surgeons Dr. Daniel V. Zimmer, Dr. Brian Jewart, Dr. Lisa M. Cibik, Dr. Miguel Busquets, Dr. John P. Nairn and Dr. Martin Boscarino have been a leader in providing Pennsylvania eye care. [click link for full article]
(more...)


Childhood Influenza Immunization Coalition Encourages Vaccination Throughout The Influenza Season

To raise awareness of the need to vaccinate more infants, children and adolescents against influenza, the Centers for Disease Control and Prevention (CDC), in conjunction with Families Fighting Flu, declared, November 27, as the first ever "Children's Flu Vaccination Day. [click link for full article]
(more...)


Ikaria’s INOmax(R) (Nitric Oxide) For Inhalation Approved In Australia

Ikaria Holdings, Inc., through its subsidiary INO Therapeutics LLC, announced that it has received approval from Australia's regulatory body, the Therapeutic Goods Administration (TGA), for INOmax (nitric oxide) for inhalation. INOmax has been designated an orphan drug by the TGA. The Australian Orphan Drug Act provides a pathway for the development of medical products to treat rare disorders. [click link for full article]
(more...)


Secondhand Smoke Damages Lungs: Novel MRI Technique Offers Proof

For the first time, researchers have identified structural damage to the lungs caused by secondhand cigarette smoke.The results of the study, conducted by researchers at the University of Virginia School of Medicine in Charlottesville and The Children's Hospital of Philadelphia in Pennsylvania, were presented at the annual meeting of the Radiological Society of North America (RSNA). [click link for full article]
(more...)


Heavier People Affected More By Ozone

A new study provides the first evidence that people with higher body mass index (BMI) may have a greater response to ozone than leaner people. Short-term exposure to atmospheric ozone has long been known to cause a temporary drop in lung function in many people. This is the first study in humans to look at whether body weight influenced how much lung function falls after acute ozone exposure. [click link for full article]
(more...)


Portopulmonary Hypertension: Bosentan Could Give A Survival Advantage

The term portopulmonary hypertension refers to the development of pulmonary arterial hypertension (PAH) in patients with liver disease and portal hypertension. Approximately 1-2% of patients with chronic liver disease develop portopulmonary hypertension and the mortality associated with this condition reaches up to 50% within one year after diagnosis. [click link for full article]
(more...)


Clinical And Familial Risk Factors For COPD Exacerbations

Exacerbations of chronic obstructive pulmonary disease (COPD) substantially impair quality of life and increase the burden of illness in individuals with COPD. Though relatives of COPD patients have increased risk for COPD, increased risk for COPD exacerbations in relatives has not been demonstrated. [click link for full article]
(more...)


Lung Patients Should Be Careful On Flights

Up to 10% of in-flight medical emergencies involve lung disease, according to major airlines' statistics. In the USA, it is the third most common medical reason for emergency landings, after cardiac and neurological problems.And it is not only the patients themselves who suffer when they experience respiratory complications during a flight. [click link for full article]
(more...)


Sanofi Pasteur Supports National Influenza Vaccination Week

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (NYSE: SNY), joins the influenza immunization community in recognizing the importance of National Influenza Vaccination Week (NIVW) by supporting educational activities that raise awareness of influenza immunization recommendations and the need to continue to vaccinate throughout the holidays, in December, January, and beyond. NIVW (November 26-December 2) is sponsored by the U.S. [click link for full article]
(more...)


Tamiflu And Relenza Should Have Psychiatric Side Effects Warning, Say Regulators

After receiving reports of patients experiencing delirium, psychosis and hallucinations, US FDA staff recommend that flu drugs, Tamiflu and Relenza should carry warnings about possible side-effects. Tamiflu is made by Roche Holdings, Relenza is made by GSK (GlaxoSmithKline). Tamiflu (oseltamivir) is a pill, while Relenza (zanamivir) is inhaled. [click link for full article]
(more...)